1. Zhou, Bin, Sha, Shanshan, Wang, Qi, Zhu, Jinjin, Dong, Liyun. 2024. The prognostic implications of cuproptosis-related gene signature and the potential of PPIC as a promising biomarker in cutaneous melanoma. In Pigment cell & melanoma research, 37, 864-880. doi:10.1111/pcmr.13185. https://pubmed.ncbi.nlm.nih.gov/39115044/
2. Yin, Honghao, Sun, Lili, Yuan, Yuan, Zhu, Yanmei. 2024. PPIC-labeled CAFs: Key players in neoadjuvant chemotherapy resistance for gastric cancer. In Translational oncology, 48, 102080. doi:10.1016/j.tranon.2024.102080. https://pubmed.ncbi.nlm.nih.gov/39116799/
3. Yang, Xin, Shu, Bo, Zhou, Yingxia, Li, Zhuan, He, Chao. 2021. Ppic modulates CCl4-induced liver fibrosis and TGF-β-caused mouse hepatic stellate cell activation and regulated by miR-137-3p. In Toxicology letters, 350, 52-61. doi:10.1016/j.toxlet.2021.06.021. https://pubmed.ncbi.nlm.nih.gov/34224798/
4. Gao, Yuan-Feng, Zhu, Tao, Mao, Chen-Xue, Zhou, Hong-Hao, Liu, Zhao-Qian. 2016. PPIC, EMP3 and CHI3L1 Are Novel Prognostic Markers for High Grade Glioma. In International journal of molecular sciences, 17, . doi:. https://pubmed.ncbi.nlm.nih.gov/27801851/
智鼠故事 
